Burleson & Company, LLC Viatris Inc Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
A detailed history of Burleson & Company, LLC transactions in Viatris Inc stock. As of the latest transaction made, Burleson & Company, LLC holds 428 shares of VTRS stock, worth $4,442. This represents 0.0% of its overall portfolio holdings.
Number of Shares
428
Previous 428
-0.0%
Holding current value
$4,442
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VTRS
# of Institutions
1,099Shares Held
945MCall Options Held
3.49MPut Options Held
2.6M-
Vanguard Group Inc Valley Forge, PA142MShares$1.47 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY93.3MShares$969 Million0.03% of portfolio
-
State Street Corp Boston, MA62.8MShares$651 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD57.9MShares$601 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$596 Million3.85% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...